Johansen Sara L, Lerma Klaira, Shaw Kate A
Stanford University School of Medicine, Li Ka Shing Building, 291 Campus Drive, Stanford, CA, USA 94305.
Stanford University, Department of Obstetrics and Gynecology, Division of Family Planning Services and Research, 300 Pasteur Drive, HG 332, Palo Alto, CA, USA 94305.
Contraception. 2017 Oct;96(4):248-253. doi: 10.1016/j.contraception.2017.06.004. Epub 2017 Jun 20.
The objective was to assess the frequency of documented contraceptive and fertility preservation counseling for women treated for breast cancer.
We conducted a chart analysis of female breast cancer patients (n=211) ages 18-45 years receiving chemotherapy treatment at Stanford Comprehensive Cancer Center from 2010 to 2014. Primary outcomes of contraceptive counseling and fertility preservation counseling documentation were assessed for frequency. Secondary outcomes included pregnancy testing, contraception use and pregnancy during treatment.
Among the total sample (n=211), sexual activity was documented in 24% of patients (n=51). Fifty-one percent (n=108) of patients received pregnancy testing prior to initiation of treatment. Past contraception use was documented in 74% of patients (n=156) and current contraception use in 25% (n=53). Twenty-six percent of patients received fertility preservation counseling alone (n=54), 10% received contraceptive counseling alone (n=22), and 12% received both types of counseling (n=25). Patients were three times more likely to receive contraceptive counseling if using contraception at diagnosis [odds ratio (OR) 3.1, confidence interval (CI) 1.1-9.1, p=.04], and older women were significantly less likely to receive counseling (OR 0.2, CI 0.1-1.0, p=.04). Two patients became pregnant and had an abortion during treatment (1%), and neither patient was using contraception nor received contraceptive or fertility preservation counseling.
Documentation of fertility preservation counseling occurs more frequently than contraceptive counseling, but both occur suboptimally. Lack of documentation does not allow us to conclude that counseling did not occur, but it suggests the need to improve documentation and increase awareness of contraceptive needs and counseling.
Women undergoing breast cancer treatment do not consistently receive counseling on contraception or fertility preservation as a part of their care. Efforts are needed to ensure that women treated for breast cancer routinely receive counseling about fertility preservation and contraceptive options.
评估接受乳腺癌治疗的女性中记录在案的避孕和生育力保存咨询的频率。
我们对2010年至2014年在斯坦福综合癌症中心接受化疗的18至45岁女性乳腺癌患者(n = 211)进行了图表分析。评估避孕咨询和生育力保存咨询记录的主要结果的频率。次要结果包括妊娠试验、治疗期间的避孕使用情况和妊娠情况。
在总样本(n = 211)中,24%的患者(n = 51)记录有性活动。51%(n = 108)的患者在开始治疗前接受了妊娠试验。74%的患者(n = 156)记录有过去的避孕使用情况,25%(n = 53)的患者记录有当前的避孕使用情况。26%的患者仅接受了生育力保存咨询(n = 54),10%的患者仅接受了避孕咨询(n = 22),12%的患者接受了两种类型的咨询(n = 25)。诊断时使用避孕措施的患者接受避孕咨询的可能性是未使用避孕措施患者的三倍[比值比(OR)3.1,置信区间(CI)1.1 - 9.1,p = 0.04],年龄较大的女性接受咨询的可能性显著较低(OR 0.2,CI 0.1 - 1.0,p = 0.04)。两名患者在治疗期间怀孕并堕胎(1%),两名患者均未使用避孕措施,也未接受避孕或生育力保存咨询。
生育力保存咨询的记录比避孕咨询更频繁,但两者的记录情况都不理想。缺乏记录使我们无法得出未进行咨询的结论,但这表明需要改进记录并提高对避孕需求和咨询的认识。
接受乳腺癌治疗的女性在其护理过程中并非始终接受关于避孕或生育力保存的咨询。需要做出努力以确保接受乳腺癌治疗的女性常规接受关于生育力保存和避孕选择的咨询。